Company Holds 150+ Patents For Fibroblast-Based Therapeutics And Cures For Chronic Diseases
FibroBiologics To Join Russell 2000 Index; Effective July 1 Following Annual Reconstitution
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.